[Asia Economy Reporter Lee Jung-yoon]
▲Canaria Bio = Acquisition before maturity after issuing the 2nd series of anonymous, interest-bearing, unsecured private convertible bonds (CB) worth KRW 11,028,340,000
▲Prostemics = Changed head office location from 22 Apgujeong-ro 14-gil, Seoul to 58 Wangsimni-ro, Seongdong-gu, Seoul FORHU. Acquisition before maturity after issuing the 2nd series of anonymous, interest-bearing, unsecured private convertible bonds (CB) worth KRW 750,000,000. Designated as a corporation with delayed disclosure
▲LX Semicon = Q2 sales increased by 33.4% year-on-year to KRW 599,159,000,000; operating profit increased by 14.7% to KRW 109,589,000,000; net profit increased by 13.9% to KRW 83,032,000,000
▲Kopra = Q2 sales increased by 26.90% year-on-year to KRW 64,574,000,000; operating profit decreased by 50.21% to KRW 3,190,000,000; net profit decreased by 25.82% to KRW 5,280,000,000
▲Kwangjin Industrial = New facility investment for relocating headquarters to Busan Gijang worth KRW 19,100,000,000
▲Wonik Holdings = Subsidiary Design to Innovation incorporated
▲Hansong Neotek = Formal delisting reason resolved after substantive review of listing eligibility; further procedures to proceed
▲SillaJen = Changed CEO from Jang Dong-taek to Kim Jae-kyung. CEO Kim Jae-kyung and inside director Park Sang-geun granted stock options for 350,000 and 160,000 common shares respectively
▲KH Electronics = Signed project management agency contract worth KRW 3,000,000,000 with Pyeongchang Blue Development
▲Seojin System = Decided to provide debt guarantee worth KRW 46,480,000,000 for overseas subsidiary SEOJIN VIETNAM
▲Ewha Electric = Decided to provide debt guarantee worth KRW 23,213,700,000 for affiliate GIE
▲Jungang Vaccine = Q2 sales increased by 11.3% year-on-year to KRW 11,158,000,000; operating profit decreased by 14.1% to KRW 876,000,000; net profit decreased by 29.2% to KRW 1,580,000,000
▲Jusung Engineering = Q2 sales increased by 64.6% year-on-year to KRW 118,976,000,000; operating profit increased by 187.4% to KRW 34,626,000,000; net profit increased by 161.6% to KRW 28,783,000,000
▲IOK = Decided to acquire 10,766,176 shares of Jayjun Cosmetic worth KRW 27,523,100,000
▲THQ = Appointed Kim Bong-gwan as managing director
▲H&B Design = Changed head office location from 3rd floor, 228 Dosan-daero, Gangnam-gu, Seoul to 301 Teheran-ro, Gangnam-gu, Seoul. Decided to issue the 7th series of anonymous, interest-bearing private convertible bonds (CB) worth KRW 3,000,000,000
▲Stonebridge Ventures = Signed a treasury stock trust contract worth KRW 4,000,000,000 with Shinhan Financial Investment
▲WI = Withdrawn decision to issue the 16th series of anonymous, unsecured private convertible bonds (CB)
▲Cellid = Approved IND for phase 1/2 clinical trial of COVID-19 preventive vaccine AdCLD-CoV19-1 OMI
▲Korea Technology = Decided to provide collateral worth KRW 6,240,000,000 and KRW 9,098,700,000 to major shareholder Korea Innovation
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
